Medical device firm Autonomix Medical (NASDAQ:AMIX) popped into traders’ radar on Monday, peaking at 150% before engaging in choppy trading. An announcement of a licensing agreement with RF Innovations, a privately held medical technology specialist, catapulted sentiment. The news established credibility for AMIX stock as the underlying enterprise moves to develop solutions for disorders related to the peripheral nervous system.According to the accompanying press release, the agreement centers on the Apex 6 ...